Genenta Science (GNTA)

• Market cap: $48.1M
• 1 day: 4.08%
• 5 days: 10.87%
• 1 month: 204.48%
• 3 months: 124.94%
• 6 months: 9.09%
• Year to date: 44.68%
• 1 year: -52.56%
• 5 years: -81.45%
• 10 years: -81.45%
• Sector: Healthcare
• Industry: Biotechnology

About: Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

Employees: 9